Position in LH
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$25,760
+$1,748 QoQ
Shares Held
92
+2.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#910
of 1,044 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026GW&K Investment Management, LLC holds $306,980,755 across 16 Diagnostics & Research names. LH ranks #12 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MEDP |
Medpace Holdings, Inc.
|
172,696 | $91,458,074 | |
| 2 | VCYT |
Veracyte, Inc.
|
1,416,543 | $83,193,570 | |
| 3 | NTRA |
Natera, Inc.
|
231,308 | $62,788,555 | |
| 4 | NEO |
Neogenomics Inc
|
2,129,421 | $31,068,251 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
90,608 | $20,548,988 | |
| 6 | TMO |
Thermo Fisher Scientific Inc.
|
31,463 | $15,774,289 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
3,509 | $1,847,277 | |
| 8 | DHR |
Danaher Corp /De/
|
685 | $130,478 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,760 | 92 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $24,012 | 90 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $23,080 | 92 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $32,150 | 112 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $29,401 | 112 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $13,964 | 60 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $13,759 | 60 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $12,961 | 58 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $11,600 | 57 | Shares | Sole | 2024-08-12 | |
| No filing history on record for this holder in this stock. | ||||||